Almost 50 percent of hip replacement surgeries is a trend that is on the rise among India's young population that is due to avascular necrosis.

"Till few years ago, AVN was seen amongst people with certain medical conditions such as cancer, sickle-cell anemia and Gaucher's disease. But changing lifestyles are making young Indians vulnerable to AVN," Rajput said.
"The increase in the number of patients diagnosed with avascular necrosis of the hip (femoral head) has increased in recent years throughout the world due to widespread use of corticosteroid therapy and the increase in alcohol consumption and the high incidence of local trauma," Ishwar Bohra, consultant orthopedic surgeon at New Delhi's BLK Super Speciality Hospital, told IANS.
Bohra said the main contributing factors are smoking (35 percent), alcohol (20 percent), trauma (10-12 percent) and corticosteroids (8-10 percent).
Doctors said AVN being a progressive disease, it is very difficult to reverse it.
According to Sanjay Agarwala, head, orthopaedics & traumatology at Mumbai's P.D. Hinduja National Hospital, the only treatment for AVN is with a medicine called Alendronate, a bisphosphonate. Alendronate is also most commonly used to treat osteoporosis as it prevents bone resorption.
For youth who need hip replacement, Rajput advocated the newly launched MDM X3 technology, which is a modular dual mobility hip joint system.
Source-IANS
MEDINDIA



Email










